Exosomes derived from TNF-α preconditioned bone marrow mesenchymal stem cells alleviate cisplatin-induced ototoxicity

Wei Li1, Tao Yang1, Zhiwen Zhang1

  • 1Department of Otolaryngology and Head & Neck Surgery, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.

Insights

Mesenchymal stem cell-derived exosomes (Exo) show potential in treating cisplatin-induced ototoxicity. Preconditioning exosomes with TNF-α (TNF-Exo) enhanced their ability to protect auditory function and hair cells.

Area of Science:

  • Ototoxicity research
  • Cellular and molecular biology
  • Regenerative medicine

Background:

  • Cisplatin chemotherapy can cause ototoxicity, damaging auditory function and cochlear hair cells.
  • Microglial polarization contributes to cisplatin-induced ototoxicity.
  • Exosomes derived from mesenchymal stem cells (MSCs) are being investigated for therapeutic potential.

Purpose of the Study:

  • To investigate the therapeutic effects of exosomes derived from TNF-α preconditioned bone marrow MSCs (BMSCs) on cisplatin-induced ototoxicity.
  • To explore the underlying mechanisms involving macrophage polarization and cytokine modulation.

Main Methods:

  • Ototoxicity was induced in mice using cisplatin.
  • Bone marrow MSCs were preconditioned with TNF-α.
  • Exosomes (Exo) and TNF-α preconditioned exosomes (TNF-Exo) were administered to ototoxic mice.
  • Auditory brainstem response (ABR) and hair cell counts (Myosin 7a staining) were assessed.
  • Expression of macrophage markers (Iba1, Cd86, iNOS, Cd206, Arg1) and cytokines (IL-1β, IL-6, IL-10) were analyzed.

Main Results:

  • Cisplatin exposure damaged auditory sensitivity and caused hair cell loss.
  • Both Exo and TNF-Exo treatments reversed auditory damage and reduced hair cell loss.
  • TNF-Exo administration showed more significant protective effects than Exo alone.
  • Exosome treatment modulated macrophage polarization, decreasing pro-inflammatory markers and increasing anti-inflammatory markers.
  • Exosome treatment reduced pro-inflammatory cytokines (IL-1β, IL-6) and increased anti-inflammatory cytokine (IL-10).

Conclusions:

  • TNF-α preconditioning enhances the therapeutic efficacy of BMSCs-derived exosomes against cisplatin-induced ototoxicity.
  • MSC-derived exosomes, particularly when preconditioned with TNF-α, represent a promising therapeutic strategy for ototoxicity.
  • Modulating macrophage polarization and cytokine balance is a key mechanism of exosome-mediated protection.